IP-6 is a normal component of a plant-based diet, and anyone who eats whole grains, beans, nuts or seeds consumes it daily. In supplement form the reported side effects are generally mild and transient, most often digestive upset such as nausea, gas or diarrhoea, with headache and fatigue also listed in drug reference monographs. The FDA has issued a no-questions response to a GRAS notice for phytic acid, though it is worth knowing that the notice covers its use as a food additive and capsule ingredient at low percentages, not gram-level supplementation as an active ingredient. As with any supplement, safety at typical doses is not the same as proven benefit.

Home · Blog · IP-6 in Immune Support

Ingredient, Explained

IP-6 in Immune Support: Clinical Dose and Mechanism

Q: What is IP-6?

IP-6 stands for inositol hexaphosphate, also written as InsP6 or myo-inositol hexakisphosphate. It is the same molecule commonly known as phytic acid or phytate. Structurally it is an inositol ring carrying six phosphate groups, which gives it strong antioxidant activity and a strong ability to bind mineral ions such as calcium, iron and zinc. It occurs naturally in seeds, cereals, legumes and nuts, with rice bran among the richest food sources, and it is also present inside human cells, where it participates in cell signalling, DNA repair and cellular housekeeping.

Q: What does IP-6 do for the immune system?

The immune rationale for IP-6 rests mainly on natural killer cell activity. Natural killer cells are white blood cells that identify and destroy infected or abnormal cells without needing prior exposure. In 1989, researchers at the University of Maryland reported that IP-6 enhanced natural killer cell activity in mice, and follow-up work in rats reported the same direction of effect. Cell-culture studies support a similar picture. It is important to be precise here: this evidence is from animals and laboratory cell cultures, not from humans. We could not find a single published human study measuring IP-6's effect on natural killer cell activity. These statements have not been evaluated by the FDA.

Q: What is a clinical dose of IP-6?

There is no established standard, which is the honest answer. No human dose-determination study for IP-6 has been published. The doses quoted as recommended, roughly 1 to 2 grams per day for general use and 8 to 12 grams per day in therapeutic contexts, were extrapolated from animal data by the field's own lead researchers, who state plainly that they made that extrapolation in the absence of a human dose study. Actual human trials have used amounts ranging from about 600 milligrams up to 6 grams per day depending on the study and the population. Because there is no agreed reference dose, the phrase clinical dose has no fixed meaning for this ingredient.

TransferFactorMax.com Editorial Updated August 4, 2026 9-min read

TL;DR

IP-6 is phytic acid. Inositol hexaphosphate — the same molecule found in rice bran, beans and whole grains, and inside your own cells, where it helps run cell signalling and DNA repair.
The immune rationale is natural killer cells. IP-6 enhanced NK-cell activity in mice (1989) and rats (2005), and in cell culture. That's a real, replicated finding — in animals.
There are zero human immune trials of IP-6. We looked hard. No RCTs, no small studies, no meta-analyses on IP-6 and immune function in people.*
"Clinical dose" has no fixed meaning here. No human dose-determination study for IP-6 exists; published human doses run from 0.6 g to 6 g/day, and 4Life doesn't disclose the amount in Max.
It binds zinc — genuinely. That's worth knowing in a formula that also contains zinc, and it's the honest caveat nobody else on this keyword mentions.

IP-6 (inositol hexaphosphate) is a naturally occurring compound found in seeds, cereal grains, legumes and nuts, and present inside virtually all mammalian cells. Chemically it is an inositol ring bearing six phosphate groups — the same molecule that nutrition science has long called phytic acid or phytate.¹ It is included in several immune-support supplements, including 4Life Transfer Factor® Max, on the strength of preclinical research suggesting it enhances the activity of natural killer cells.² This article explains what IP-6 actually is, the mechanism proposed for its immune role, the doses that have genuinely been used in human research, the mineral-binding question that most product pages skip, and what the widely repeated phrase "a clinical dose of IP-6" does — and does not — establish.*

We write these ingredient pieces the way we'd want one written for our own family: name the real evidence, label how much weight it can carry, and say plainly where the record runs out. On IP-6 that last part matters more than usual, because the gap between how confidently this ingredient is marketed and what has actually been measured in humans is the widest of anything in this formula.

IP-6 — key facts

Also known as: Inositol hexaphosphate · InsP6 · phytic acid · phytate · myo-inositol hexakisphosphate
Chemical form: Inositol ring with six phosphate groups; strong mineral-chelating and antioxidant capacity
Food sources: Rice bran, wheat bran, legumes, nuts, seeds, whole grains
In the body: Present in nearly all human cells; involved in cell signalling, DNA repair, cell-cycle regulation
Immune rationale: Enhanced natural killer (NK) cell activity — demonstrated in rodents and cell culture
Human immune trials: None published
Doses in human studies: ~0.6 g to 6 g/day (in non-immune contexts)
Amount in Max: Not disclosed — part of a proprietary blend

What IP-6 actually is

Start with the naming, because it explains a lot of the confusion. IP-6, phytic acid and phytate are the same compound. Which name gets used tends to signal what the writer wants you to think about it.

Nutrition science has traditionally called it phytic acid and treated it as an antinutrient — a plant compound that binds dietary minerals and reduces how much of them you absorb. That's why traditional food preparation soaks, sprouts and ferments grains and beans: those steps lower phytate. Supplement marketing calls the same molecule IP-6 and emphasises a different set of properties — antioxidant capacity, roles in cell signalling and DNA repair, and the NK-cell work discussed below.

Neither framing is dishonest. They are both true descriptions of one molecule, and a complete picture holds both at once: IP-6 is a bioactive compound with genuine cellular functions and a well-documented mineral-binding effect. Any page that gives you only one half is selling you something.

Worth knowing: your body makes IP-6 on its own, synthesising it from inositol. It is present in nearly every cell you have, at high concentrations, where it participates in signal transduction, DNA repair and cell-cycle regulation.¹ It is not a foreign or exotic substance. If you eat beans, oats, brown rice or nuts, you consumed some this week.

The immune mechanism: natural killer cells Preclinical

Natural killer cells are a class of white blood cell that act as immune first responders. Unlike T and B cells, they don't need prior exposure to a pathogen to act — they patrol for cells displaying stress signals or missing normal identity markers, and destroy them on contact. They're part of innate immunity: fast, broad, no memory required.

The foundational IP-6 immune finding comes from Baten and colleagues in 1989, working in A.M. Shamsuddin's lab at the University of Maryland School of Medicine and publishing in Carcinogenesis.² Working in mice, they reported that IP-6 both raised baseline NK-cell activity and restored NK activity that had been chemically suppressed. They also found that treating spleen cells with IP-6 in culture increased NK cytotoxicity in a dose-dependent way, and that plain inositol potentiated the effect — which is why IP-6 supplements are so often sold as "IP-6 + inositol."

A 2005 rat study from Qingdao University Medical College reported the same direction of effect on blood NK-cell activity.³ So the finding has been replicated across two rodent species by independent groups, which is more than can be said for many supplement ingredients.

Now the part that most pages leave out.

Every published measurement of IP-6's effect on natural killer cells has been made in a mouse, a rat, or a dish. We could not find one made in a human being.

That is not a rhetorical flourish — it's the search result. Multiple targeted searches for human trials of IP-6 and NK-cell activity returned nothing. Human NK-cell supplement trials do exist for other ingredients, so the absence isn't a quirk of how this research gets published. It simply hasn't been done for IP-6.

Rodent immunology translates to humans unpredictably. Mouse and human NK cells differ in receptor repertoire, tissue distribution and activation thresholds, and the history of immunology is full of compounds that lit up in mice and did nothing in people. A replicated animal finding is a legitimate reason to be interested. It is not a reason to be confident.

What "a clinical dose" actually means

4Life's own materials describe Transfer Factor Max as containing "a clinical dose of IP-6." That phrase appears widely across product copy and affiliate pages, including — until this article — parts of this site. It sounds precise. It isn't, and here's why.

There is no human dose-determination study for IP-6. The doses commonly quoted as "recommended" — roughly 1–2 g/day for general use, 8–12 g/day in therapeutic contexts — were extrapolated from animal data by Vucenik and Shamsuddin, the field's own lead researchers. They say so themselves, in print: the figures were arrived at "in the absence of a dose-determination study in humans."⁴

Human trials that have used IP-6 landed in a wide range, and none of them measured immunity:

IP-6 doses actually used in published human studies

Study	Dose	Population	What it measured
Bačić et al. 2010	6 g/day (IP-6 + inositol)	14 patients undergoing chemotherapy	Quality-of-life and blood-count measures
Sanchis et al. 2018	~1.14 g/day	35 adults with type 2 diabetes	Glycation markers
Ikenaga et al. 2019	600 mg (single dose)	48 healthy volunteers	Serum uric acid
Grases et al. 2006	400 mg (single dose)	6 healthy volunteers	Absorption with vs. without food
Any study	—	—	Immune function — none found

A ten-fold spread across four studies, in four different populations, measuring four different things — none of them immunity. There is no consensus "clinical dose" of IP-6 to match, because no study has established one.

The second half of the problem is disclosure. 4Life does not publish how much IP-6 is in Transfer Factor Max. IP-6 appears within a proprietary blend, where only the combined weight of all the blend's ingredients is listed and no individual amounts are broken out.

Proprietary blends are legal, extremely common, and have a defensible rationale — they protect formulation work from being copied. 4Life is entirely ordinary in using one. But the consequence is unavoidable: you cannot check the claim. With no published number and no established reference dose, "a clinical dose of IP-6" is a phrase that cannot be verified or falsified by a customer. We're not going to repeat it on this site as though it were a specification.

A note on where IP-6 research comes from

Most published IP-6 research sits in oncology, and the researchers who have driven the field for three decades are also its most enthusiastic advocates, with commercial history around IP-6 supplements. That doesn't invalidate the work, but it does mean the most positive summaries of IP-6 are not independent ones.

None of that research is a claim about this product. Transfer Factor Max is a dietary supplement, not a treatment for any disease, and nothing in the IP-6 literature should be read as suggesting it prevents, treats or cures anything. If you are dealing with a serious illness, that is a conversation for your physician, not a supplement label.*

The zinc question — an honest caveat

Here is the part we'd want flagged if we were the reader rather than the publisher.

IP-6 binds zinc. This isn't contested: phytic acid chelates calcium, iron, magnesium and zinc in the digestive tract, which is precisely why nutrition science labelled it an antinutrient in the first place. Memorial Sloan Kettering lists mineral supplements under IP-6's interactions, noting that phytic acid "can bind with calcium, iron, magnesium, and zinc in the stomach and reduce their bioavailability."⁵ Standard drug-reference monographs carry the same caution.⁶

Transfer Factor Max contains zinc — at 90% of the Daily Value — in the same capsule as the IP-6. That is the maximum-contact scenario, not a separated one.

So does it matter? The honest answer is that nobody has tested it. Specifically:

The interaction is real and acknowledged by mainstream clinical references. It is not a myth to be waved off.
Whether it's clinically meaningful at supplement doses in a well-nourished person is genuinely unsettled. Researchers specialising in IP-6 argue the effect is context-dependent and negligible alongside a varied diet, and that no mineral deficiencies have been reported in lifetime animal studies — though, again, those researchers are the compound's leading advocates.
No human study has tested supplemental IP-6 together with supplemental zinc and measured zinc status. Not in either direction. Anyone asserting the combination is definitely fine — or definitely a problem — is reasoning past the evidence.

On timing, there is one directly relevant human study. Grases and colleagues gave six healthy volunteers a 400 mg dose on an empty stomach, on an empty stomach with an alkalinising agent, and on a full stomach, and found no meaningful difference in absorption over eight hours. Their conclusion was that IP-6 supplements "can be consumed either during or between meals with the same efficacy."⁷ The important caveat: that study measured IP-6 absorption, not mineral status. It does not tell you that taking IP-6 with food protects your zinc. 4Life directs that Max be taken with 8 oz of water and food regardless.

If you're taking a separate zinc, iron or calcium supplement and want to be cautious, spacing it a few hours from your Max dose is a reasonable, no-cost precaution — not because anyone has proven you need to, but because the downside is nil.

Where the evidence stands

IP-6 evidence, honestly tiered

Evidence type	What exists	Strength
Cell culture	Extensive — decades of work across many cell lines	Suggestive of mechanism only
Animal studies	Extensive — mice and rats, including the replicated NK-cell finding	Real, replicated, but rodent
Human — immune	None found	No evidence base
Human — other	A handful of small trials (n=6 to n=48) on absorption, uric acid, glycation	Small, unrelated endpoints
Systematic reviews	One (2002), which noted the great majority of studies were in animals	Confirms the preclinical picture
Meta-analyses	None for immune function	—

Evidence-strength labels are our editorial team's plain-language assessment, not formal scientific grades. Memorial Sloan Kettering's summary of the field: laboratory studies have shown effects, but clinical data are lacking and large-scale studies are needed.⁵

Safety, and who should be careful

IP-6 has a reassuring safety profile in the ordinary sense: it's a normal part of a plant-based diet, and reported side effects in supplement form are typically mild and transient — digestive upset, gas, occasionally headache or fatigue.⁶ The FDA issued a "no questions" response to a GRAS notice for phytic acid, though it's worth being precise about what that covers: use as a food additive and capsule ingredient at low percentages, not gram-level supplementation as an active ingredient.

Standard drug-reference guidance advises caution or avoidance for several groups:

Pregnancy and breastfeeding — advised against.
Anticoagulants, antiplatelet drugs and NSAIDs — IP-6 showed antiplatelet activity in laboratory studies, so references flag a theoretical bleeding-risk interaction while noting the clinical relevance is unknown.⁵
Mineral supplements — see the zinc section above.
Osteoporosis, mood disorders, diabetes — extra caution advised.⁶
Upcoming surgery — tell your physician.

Safety at typical doses is not the same thing as proven benefit, and it's the second one that's missing here.

So how should you think about IP-6 in Max?

Our honest read: IP-6 is a reasonable supporting ingredient, and it is not the reason to buy this product.

The case for Transfer Factor Max rests on its transfer factor content — 900 mg per serving across colostrum-, egg- and plant-derived peptides — and that's where the strongest evidence sits, including the peer-reviewed, independently-conducted Yu et al. 2024 trial we walk through in our breakdown of the clinical studies behind Max.⁸ IP-6 is part of a supporting cast that also includes a super-mushroom blend, vitamin C, vitamin D3 and zinc.

If you're buying Max, buy it for the transfer factors. Treat IP-6 as a plausible, food-derived, safe-at-normal-doses extra with an interesting rodent literature behind it and no human immune data. That's a fair description, and it's more than most supplement ingredients can claim — but it's a long way from the confidence with which the phrase "clinical dose" tends to get deployed.

And if a page tells you IP-6 is clinically proven to boost your immune system, you now know enough to ask which human study they're referring to. There isn't one.*

For the full ingredient-by-ingredient breakdown of what's in the formula, see what's inside Transfer Factor Max. For the proposed mechanism behind transfer factors themselves — Recognize, Respond, Remember, Renew — see the science page, and our FAQ covers dosing and daily-use questions.

Frequently asked questions

What is IP-6?

IP-6 stands for inositol hexaphosphate, also written InsP6 or myo-inositol hexakisphosphate — the same molecule commonly known as phytic acid or phytate. Structurally it's an inositol ring carrying six phosphate groups, which gives it strong antioxidant activity and a strong ability to bind minerals like calcium, iron and zinc. It occurs naturally in seeds, cereals, legumes and nuts, with rice bran among the richest sources, and it's also present inside human cells, where it participates in cell signalling, DNA repair and cellular housekeeping.

What does IP-6 do for the immune system?

The immune rationale rests mainly on natural killer (NK) cell activity — white blood cells that identify and destroy infected or abnormal cells without needing prior exposure. In 1989, University of Maryland researchers reported that IP-6 enhanced NK-cell activity in mice, and follow-up work in rats reported the same direction of effect. Cell-culture studies support a similar picture. To be precise: this evidence is from animals and laboratory cell cultures, not humans. We could not find a single published human study measuring IP-6's effect on NK-cell activity.*

Is IP-6 clinically proven to boost immunity?

No. There are no large randomized controlled trials of IP-6 for immune function in healthy people, and we found no small ones either. The NK-cell findings underpinning the immune rationale are animal and in vitro results. Human IP-6 trials do exist, but they were conducted in other contexts and measured other endpoints entirely — blood sugar markers, uric acid, absorption. Memorial Sloan Kettering summarises the position bluntly: laboratory studies have shown effects, but clinical data are lacking and large-scale studies are needed. IP-6 is best described as a mechanistically plausible, extensively studied preclinical ingredient — not a proven immune therapy.

What is a "clinical dose" of IP-6?

There is no established standard — that's the honest answer. No human dose-determination study for IP-6 has been published. The doses quoted as "recommended" (roughly 1–2 g/day generally, 8–12 g/day therapeutically) were extrapolated from animal data by the field's own lead researchers, who state plainly that they did so in the absence of a human dose study. Actual human trials have used from about 600 mg up to 6 g/day depending on study and population. With no agreed reference dose, "clinical dose" has no fixed meaning for this ingredient.

How much IP-6 is in Transfer Factor Max?

4Life does not publish the individual milligram amount. Its materials describe Max as containing "a clinical dose of IP-6" without stating a number, and IP-6 appears within a proprietary blend where only the combined weight is disclosed. Proprietary blends are legal and common across the supplement industry, and 4Life isn't unusual in using one — but it does mean the IP-6 amount can't be independently verified by a customer or compared against research doses. If exact per-ingredient amounts matter to you, that's a fair reason to weigh this product carefully.

Does IP-6 block zinc absorption?

IP-6 does bind zinc, and this is well established rather than disputed. Phytic acid chelates calcium, iron, magnesium and zinc in the digestive tract — which is why it's sometimes called an antinutrient — and both Memorial Sloan Kettering and standard drug-interaction references advise caution when combining IP-6 with mineral supplements. What's genuinely unsettled is whether it matters clinically at supplement doses for a well-nourished person eating a varied diet. IP-6 researchers argue the effect is context-dependent and negligible in that setting, though they're also the compound's leading advocates. We found no human study testing supplemental IP-6 alongside supplemental zinc in either direction, so anyone telling you the combination is definitely fine — or definitely a problem — is going beyond the evidence.

Should I take IP-6 with food or on an empty stomach?

For IP-6 absorption itself, it appears not to matter. A small 2006 human study of six healthy volunteers compared a 400 mg dose taken on an empty stomach, on an empty stomach with an alkalinising agent, and on a full stomach, and found no meaningful difference in absorption over eight hours; the authors concluded IP-6 supplements can be taken with meals or between them with equal effectiveness. One important caveat: that study measured IP-6 absorption, not mineral status, so it doesn't tell you whether taking IP-6 with food protects zinc or iron absorption. 4Life directs that Transfer Factor Max be taken with food and 8 oz of water regardless.

Is IP-6 safe?

IP-6 is a normal component of a plant-based diet — anyone eating whole grains, beans, nuts or seeds consumes it daily. In supplement form, reported side effects are generally mild and transient: most often digestive upset such as nausea, gas or diarrhoea, with headache and fatigue also listed in drug reference monographs. The FDA issued a "no questions" response to a GRAS notice for phytic acid, though that notice covers its use as a food additive and capsule ingredient at low percentages, not gram-level supplementation as an active ingredient. As with any supplement, safety at typical doses is not the same as proven benefit.

Who should avoid IP-6?

Standard drug-reference guidance advises against IP-6 during pregnancy or breastfeeding, and recommends extra caution for people with osteoporosis, mood disorders or diabetes. IP-6 has demonstrated antiplatelet activity in laboratory studies, so references flag a theoretical increased bleeding risk alongside anticoagulants, antiplatelet drugs and NSAIDs, while noting the clinical relevance is not known. Anyone taking mineral supplements, scheduled for surgery, or managing a chronic condition should talk with their healthcare provider before starting a product containing IP-6.

Is IP-6 the same as phytic acid?

Yes. IP-6, inositol hexaphosphate, InsP6, phytic acid, phytate and myo-inositol hexakisphosphate all refer to the same compound. The naming difference is mostly framing rather than chemistry. Nutrition literature has traditionally called it phytic acid and treated it as an antinutrient because it binds dietary minerals; supplement literature calls it IP-6 and emphasises its antioxidant and cell-signalling roles. Both describe the same molecule, and a complete picture includes both.

Where does IP-6 come from?

In the diet, from seeds, cereal grains, legumes and nuts, where it serves as the plant's phosphorus storage molecule — rice bran and wheat bran are among the most concentrated sources. Supplemental IP-6 is typically manufactured from rice bran, and 4Life lists Japan as the source country for the IP-6 in its formulas. IP-6 is also synthesised inside human cells from inositol, so your body maintains its own supply independently of diet.

References

Memorial Sloan Kettering Cancer Center, Integrative Medicine — Inositol Hexaphosphate (About Herbs database). Chemistry, food sources, cellular roles, interactions, and the summary that clinical data are lacking.
Baten, A., Ullah, A., Tomazic, V.J., & Shamsuddin, A.M. (1989). Inositol-phosphate-induced enhancement of natural killer cell activity correlates with tumor suppression. Carcinogenesis, 10(9), 1595–1598. Murine (mouse) model; in vivo and in vitro.
Zhang, Z., Song, Y., & Wang, X.L. (2005). Inositol hexaphosphate-induced enhancement of natural killer cell activity correlates with suppression of colon carcinogenesis in rats. World Journal of Gastroenterology, 11(32), 5044–5046. Rat model.
Vucenik, I., & Shamsuddin, A.M. (2006). Protection against cancer by dietary IP6 and inositol. Nutrition and Cancer, 55(2), 109–125. Source of the extrapolated dose figures, stated by the authors as made in the absence of a human dose-determination study.
MSKCC, as above — herb–drug interactions, including mineral binding (citing Hurrell, R.F., Journal of Nutrition, 2003) and antiplatelet activity (citing Vucenik et al., Anticancer Research, 1999, an in vitro study).
Drugs.com / UpToDate monograph — Inositol Hexaphosphate. Adverse effects, contraindications, and drug-interaction cautions.
Grases, F., Costa-Bauza, A., Perelló, J., Isern, B., Vucenik, I., et al. (2006). Influence of concomitant food intake on the excretion of orally administered myo-inositol hexaphosphate in humans. Journal of Medicinal Food, 9(1), 72–76. n=6; measured IP-6 absorption, not mineral status.
Yu, L., Iloba, I., Cruickshank, D., & Jensen, G.S. (2024). Feasibility trial exploring immune-related biomarkers after consuming a nutraceutical supplement containing colostrum- and egg-based low-molecular-weight peptides. Current Issues in Molecular Biology, 46, 6710–6724. Peer-reviewed; conducted at NIS Labs. Concerns the transfer factor peptides, not IP-6.
Bačić, I. et al. (2010). Efficacy of IP6 + inositol in the treatment of breast cancer patients receiving chemotherapy. Journal of Experimental & Clinical Cancer Research, 29, 12. Source of the 6 g/day figure and of the quoted absence of a human dose-determination study.
Fox, C.H., & Eberl, M. (2002). Phytic acid (IP6), novel broad spectrum anti-neoplastic agent: a systematic review. Complementary Therapies in Medicine, 10(4), 229–234. Noted that the great majority of reviewed studies were conducted in animals.

*These statements have not been evaluated by the Food and Drug Administration. Transfer Factor Max is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease. This article summarizes published third-party research on the ingredient IP-6 for educational purposes; it is not medical advice and does not represent a health claim about any product. Much of the published IP-6 literature was conducted in oncology research contexts and in animal models; none of it constitutes a claim that this or any dietary supplement prevents, treats or cures disease, and readers should not use it that way. "Evidence strength" labels are the editorial team's plain-language assessment, not formal scientific grades. Individual results vary. Consult your healthcare provider before beginning any new supplement program, particularly if pregnant, nursing, taking medication (including blood thinners or mineral supplements), or scheduled for surgery.